Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurobiological and Genomic Predictors of Relapse After Discontinuation of Antidepressant Treatment in Major Depressive Disorder: An Observational Prospective Study

NCT07328373 is registered in ClinicalTrials.gov with Mehmet Kemal Arikan as lead sponsor.

NCT NCT07328373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurobiological and Genomic Predictors of Relapse After Discontinuation of Antidepressant Treatment in Major Depressive Disorder: An Observational Prospective Study
Lead sponsor
Mehmet Kemal Arikan
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
February 1, 2027
Enrollment
204 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, major depressive disorder (mdd)